References
- Lu-Yao GL, Potosky AL, Albertsen PC, Wasson JH, Barry MJ, Wennberg JE. Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. J Natl Cancer Inst 1996; 88: 166–73
- Grossfeld GD, Stier DM, Flanders SC, Henning JM, Schonfeld W, Warolin K, et al. Use of second treatment following definitive local therapy for prostate cancer: data from the CaPSURE database. J Urol 1998; 160: 1398–404
- Grossfeld GD, Yu-Ping L, Lubeck DP, Broering JM, Mehta SS, Carroll PR. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol 2002; 168: 530–5
- National Cancer Institute. SEER: Surveillance, Epidemiology, and End Results. Available at: http://seer.cancer.gov.
- Available at: http://healthservices.cancer.gov/seermedicare.
- American Joint Committee on Cancer. Manual for staging of cancer, 4th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 1992.
- Shambaugh EM, Ries LG, Young JL, Kruse MA. SEER Extent of Disease 1988. Codes and coding instructions2nd ed. National Cancer Institute, Rockville, MD 1992
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–83
- Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000; 53: 1258–67
- Fowler FJ, Jr, Barry MJ, Lu-Yao GL, Wasson JH, Bin L. Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol 1996; 14: 2258–65
- Koppie TM, Grossfeld GD, Miller D, Yu J, Stier D, Broering JM, et al. Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from the CaPSURE database. J Urol 2000; 164: 81–8
- Lubeck DP, Litwin MS, Henning JM. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1996; 48: 773–7
- Potosky AL, Warren JL, Riedel ER, Klabunde CN, Earle CC, Begg CB. Measuring complications of cancer treatment using the SEER-Medicare data. Med Care 2002; 40(Suppl 8)62–8